ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

KRON Kronos Bio Inc

1.03
0.03 (3.00%)
Fuera de horario
Última actualización: 15:55:41
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kronos Bio Inc KRON NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.03 3.00% 1.03 15:55:41
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.01 1.00 1.06 1.03 1.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:01GLOBEKronos Bio to Present Clinical Update on Phase 1/2 Trial of..
21/3/202406:05GLOBEKronos Bio Reports Recent Business Progress and..
07/3/202415:05EDGAR2Form 8-K - Current report
07/3/202415:05GLOBEKronos Bio Announces Restructuring to Focus Resources on..
05/3/202415:44GLOBEKronos Bio To Present Three Posters at AACR 2024 Annual..
05/3/202406:00EDGAR2Form 8-K - Current report
27/2/202415:05GLOBEKronos Bio Announces Participation in 44th Annual Cowen..
23/2/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202419:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202419:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/1/202407:05EDGAR2Form 8-K - Current report
05/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:06GLOBEKronos Bio Announces Pipeline Update and p300 KAT Inhibitor..
13/12/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202307:00GLOBEKronos Bio Announces Participation in H.C. Wainwright 4th..
27/11/202315:05GLOBEKronos Bio Announces Participation in 35th Annual Piper..
13/11/202315:08EDGAR2Form 8-K - Current report
13/11/202315:05GLOBEKronos Bio Reports Recent Business Progress and..
13/11/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:11EDGAR2Form 8-K - Current report
02/11/202315:05GLOBEKronos Bio Announces Plan to Optimize Resource Allocation,..
02/11/202311:00GLOBEKronos Bio Presents Positive Preliminary Data from the Phase..
27/10/202307:00GLOBEKronos Bio To Present Positive Preliminary Data from Phase 1..
13/10/202311:30GLOBEKronos Bio Presents Positive Preliminary Data from Phase 1..
05/10/202307:00EDGAR2Form 8-K - Current report
04/10/202315:05GLOBEKronos Bio To Present Interim Data from Phase 1 Dose..
18/9/202307:00EDGAR2Form 8-K - Current report
17/8/202307:00EDGAR2Form 8-K - Current report
17/8/202307:00GLOBEKronos Bio Announces Departure of Chief Financial Officer..
08/8/202315:05GLOBEKronos Bio Reports Recent Business Progress and..
08/8/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:03EDGAR2Form 8-K - Current report
07/7/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202307:00GLOBEKronos Bio Names Marc Besman, Ph.D., as Senior Vice..
01/6/202315:05GLOBEKronos Bio Announces Participation in Upcoming Investor..
10/5/202315:05GLOBEKronos Bio Reports Recent Business Progress and..

Su Consulta Reciente

Delayed Upgrade Clock